top of page

4T1 Syngeneic Model

Rincon Bio offers efficacy studies using the 4T1 Syngeneic Model at our U.S.-based facilities, with direct access to the scientists conducting your study.

Model Type:
Syngeneic
Organ:
Breast
Derivation:
Primry breast cancer tumor (410.1) in a BALB/c
Mutations:
Unavailable
NCI60:
No
Weeks from stratification to termination (average):
4

4T1 Growth Curve

(Representative of studies performed at Rincon Bio)

Representative tumor growth curve for the 4T1 syngeneic model from studies performed at Rincon Bio.

For more information on this model, including available control data, please Contact Us, or request a Quote below

bottom of page